[1] ALAGGIO R, AMADOR C, ANAGNOSTOPOULOS I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasm[J]. Leukemia, 2022, 36(7):1720-1748.
[2] 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)淋巴瘤诊疗指南(2023)[M]. 北京:人民卫生出版社,2023:33-51.
[3] 中华人民共和国国家卫生健康委员会.弥漫性大B细胞淋巴瘤诊疗指南(2022年版)[EB/OL].[2023-09-21] .http://www.nhc.gov.cn/yzygj/s7659/202204/a0e67177df1f439898683e1333957c74/files/697cd66a248e4186bec17040d53a1f3f.pdf.
[4] 中华人民共和国国家卫生健康委员会.淋巴瘤诊疗指南(2022年版)[EB/OL].[2023-09-21] .http://www.nhc.gov.cn/yzygj/s7659/202204/a0e67177df1f439898683e1333957c74/files/abcfc8aae54a4c3bbcfc5c6eea87cb71.pdf.
[5] 阿尔贝托.皮洛托, 芬巴尔.C.马丁.老年综合评估[M].北京:中国协和医科大学出版社,2023:133-142.
[6] TUCCI A, MARTELLI M, RIGACCI L, et al. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation(FIL)[J]. Leuk Lymphoma, 2015, 56(4):921-926.
[7] BAI J F, HAN H X, FENG R, et al. Comprehensive geriatric assessment(CGA): a simple tool for guiding the treatment of older adults with diffuse large B-cell lymphoma in China[J]. Oncologist, 2020, 25(8):e1202-e1208.
[8] KATZ S, FORD A B, MOSKOWITZ R W, et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function[J]. JAMA, 1963, 185(12):914-919.
[9] LAWTON M P, BRODY E M. Assessment of older people: self-maintaining and instrumental activities of daily living[J]. Gerontologist, 1969, 9(3):179-186.
[10] MILLER M D, TOWERS A. A Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics(CIRS-G) [M]. Pittsburgh, PA: University of Pittsburgh, 1991.
[11] MERLI F, LUMINARI S, TUCCI A, et al. Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi[J]. J Clin Oncol, 2021, 39(11):1214-1222.
[12] LIU M A, DUMONTIER C, MURILLO A, et al. Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies [J]. Blood, 2019, 134(4):374-382.
[13] LEE S, FUJITA K, MORISHITA T, et al. Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma[J]. Br J Haematol, 2021, 192(1):100-109.
[14] CHEN L K, WOO J, ASSANTACHAI P, et al.Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment [J]. J Am Med Dir Assoc, 2020, 21(3):300-307.e2.
[15] 石汉平, 李薇.营养筛查与评估[M]. 北京:人民卫生出版社, 2021:161-163.
[16] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology:B-Cell Lymphomas, Version 6. 2023[EB/OL]. [2023-09-21] . https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480.
[17] 全国肺栓塞和深静脉血栓形成防治能力建设项目专家委员会《医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)》编写专家组. 医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)[J]. 中华医学杂志, 2022, 102(42):3338-3348.
[18] DI M, HUNTINGTON S F, OLSZEWSKI A J. Challenges and opportunities in the management of diffuse large B-Cell lymphoma in older patients[J]. Oncologist, 2021, 26(2):120-132.
[19] LUGTENBURG P J, MUTSAERS P G N J. How I treat elderly patients with DLBCL in the frontline setting[J]. Blood, 2023, 141(21):2566-2575.
[20] VAN WESTRHENEN A, SMIDT L C A, SEUTE T, et al. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review[J]. Br J Haematol, 2018, 182(3):384-403. |
